Nafamostat mesilate (NM), a synthetic serine protease inhibitor, inhibits NF-κB activation by inhibiting IκBα phosphorylation and induces apoptosis of pancreatic cancer cells [3]. The gene discussed is NFKB1; the disease is pancreatic neoplasm.